(Q44485883)

3 December 2017

title

Functional characterization of the novel antipsychotic iloperidone at human D2, D3, alpha 2C, 5-HT6, and 5-HT1A receptors (English)

1 reference

3 December 2017

Hans O Kalkman

1

1 reference

3 December 2017

Dominik Feuerbach

series ordinal

2

1 reference

3 December 2017

Erika Lötscher

series ordinal

3

1 reference

3 December 2017

Philippe Schoeffter

series ordinal

4

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

73

1 reference

3 December 2017

issue

9

1 reference

3 December 2017

page(s)

1151-1159

1 reference

A review of central 5-HT receptors and their function

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Alpha2C-adrenoceptor-overexpressing mice are impaired in executing nonspatial and spatial escape strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Molecular biology of 5-HT receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

[3H]WAYâ 100635 for 5â HT1A receptor autoradiography in human brain: a comparison with [3H]8â OHâ DPAT and demonstration of increased binding in the frontal cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

D3 receptor test in vitro predicts decreased cocaine self-administration in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

High-efficiency transformation of mammalian cells by plasmid DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

The neural correlates of the noradrenergic modulation of human attention, arousal and learning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

NMDA‐induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5‐HT1A antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

The cortical dopamine system: role in memory and cognition

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

An assessment of iloperidone for the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Iloperidone binding to human and rat dopamine and 5-HT receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Localization of alpha2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

The role of serotonin in antipsychotic drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Alpha 2-autoreceptor-mediated modulation of tyrosine hydroxylase activity in noradrenergic regions of the rat brain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

2 Cellular responsiveness to hormones and neutrotransmitters: Conversion of 3HAdenine to 3HcAMP in cell monolayers, cell suspensions, and tissue slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Inhibition of cAMP accumulation via recombinant human serotonin 5-HT1A receptors: considerations on receptor effector coupling across systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

The D3 dopamine receptor in cellular and organismal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

Novel dopamine receptors half a decade later

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900419-3

10.1016/S0024-3205(03)00419-3

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference